JO
PMD

John Overdeck’s Psychemedics Corporation PMD Stock Holding History

John Overdeck’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10,539
Closed -$217K – 3597
2017
Q4 		$217K Buy
+10,539
New +$195K ﹤0.01% 2888
2017
Q3 		– Sell
-12,460
Closed -$311K – 3288
2017
Q2 		$311K Buy
+12,460
New +$262K ﹤0.01% 2625

Other funds holding PMD

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.57B AUM 37.84% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $6B AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $1.07B AUM 34.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return

John Overdeck's PMD Position: Q1 2018 in Review

John Overdeck sold out of Psychemedics Corporation (PMD) in Q1 2018, closing a stake of 10,539 shares — an estimated $217K sold.

John Overdeck first reported a position in PMD in Q2 2017 and held it in 2 quarters. The position peaked at $311K in Q2 2017. 50 funds tracked by Wall St. Rank hold PMD as of Q1 2018.

  • John Overdeck reported no remaining Psychemedics Corporation position as of Q1 2018 after selling out during the quarter.
  • John Overdeck sold 10,539 Psychemedics Corporation shares in Q1 2018, an estimated $217K.
  • John Overdeck first reported a position in Psychemedics Corporation in Q2 2017 and held it in 2 quarters.
  • John Overdeck's Psychemedics Corporation position peaked at $311K in Q2 2017.
  • 50 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q1 2018.

Based on Two Sigma Investments's 13F filing for Q1 2018, filed 15 May 2018.